{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:09Z","timestamp":1789560129750,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":100,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cell cycle dysregulation is a hallmark of cancer and a major source of tumor heterogeneity. While large-scale cancer genomics studies have characterized recurrent copy number alterations affecting cell cycle regulators, how these alterations translate into patient-specific dynamical dysregulation remains poorly understood. Here, we develop a stochastic, human-specific model of the G2\/M cell cycle transition and integrate somatic copy number alterations to generate patient-specific perturbations of cell cycle dynamics. Copy number profiles from breast cancer patients are quantitatively mapped to model components, enabling simulation of individualized G2\/M transition behavior. Model simulations reveal that copy number alterations induce distinct dynamical regimes characterized by systematic shifts in transition timing and switching commitment. Importantly, model-derived dynamical metrics stratify patients into groups with significantly different overall survival, independently of age and molecular subtype. Patients exhibiting delayed or impaired G2\/M transitions show improved survival probability, consistent with reduced proliferative capacity. These results demonstrate that mechanistic, stochastic modeling can transform static genomic alterations into clinically relevant dynamical phenotypes, highlighting the potential of systems-level approaches to bridge cancer genomics and functional tumor behavior.<\/jats:p>","DOI":"10.1038\/s41540-026-00766-4","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:55:22Z","timestamp":1780916122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-specific modeling of G2\/M cell cycle dynamics reveals prognostic dynamical regimes driven by copy number alterations"],"prefix":"10.1038","volume":"12","author":[{"given":"Andrea","family":"Tonina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Romanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr, C. J. Cancer cell cycles. Science 274, 1672\u20131677 (1996).","journal-title":"Science"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153\u2013166 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"766_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29289","volume":"10","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma. Heliyon 10, e29289 (2024).","journal-title":"Heliyon"},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature03097","volume":"432","author":"MB Kastan","year":"2004","unstructured":"Kastan, M. B. & Bartek, J. Cell-cycle checkpoints and cancer. Nature 432, 316\u2013323 (2004).","journal-title":"Nature"},{"key":"766_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01304-w","volume":"20","author":"K Liu","year":"2020","unstructured":"Liu, K. et al. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. Cancer Cell Int. 20, 213 (2020).","journal-title":"Cancer Cell Int."},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega, F. et al. Oncogenic signaling pathways in the Cancer Genome Atlas. Cell 173, 321\u2013337.e10 (2018).","journal-title":"Cell"},{"key":"766_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14605-5","volume":"11","author":"A Bhattacharya","year":"2020","unstructured":"Bhattacharya, A. et al. Transcriptional effects of copy number alterations in a large set of human cancers. Nat. Commun. 11, 715 (2020).","journal-title":"Nat. Commun."},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1069492","volume":"295","author":"H Kitano","year":"2002","unstructured":"Kitano, H. Systems biology: a brief overview. Science 295, 1662\u20131664 (2002).","journal-title":"Science"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1146\/annurev-cellbio-100109-104122","volume":"26","author":"H-Y Chuang","year":"2010","unstructured":"Chuang, H.-Y., Hofree, M. & Ideker, T. A decade of systems biology. Annu. Rev. Cell Dev. Biol. 26, 721\u2013744 (2010).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrg2509","volume":"10","author":"DJ Wilkinson","year":"2009","unstructured":"Wilkinson, D. J. Stochastic modelling for quantitative description of heterogeneous biological systems. Nat. Rev. Genet. 10, 122\u2013133 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1091\/mbc.11.1.369","volume":"11","author":"KC Chen","year":"2000","unstructured":"Chen, K. C. et al. Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol. Biol. Cell 11, 369\u2013391 (2000).","journal-title":"Mol. Biol. Cell"},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0955-0674(02)00314-9","volume":"14","author":"JE Ferrell","year":"2002","unstructured":"Ferrell, J. E. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14, 140\u2013148 (2002).","journal-title":"Curr. Opin. Cell Biol."},{"key":"766_CR14","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1529\/biophysj.106.081240","volume":"90","author":"A Csik\u00e1sz-Nagy","year":"2006","unstructured":"Csik\u00e1sz-Nagy, A., Battogtokh, D., Chen, K. C., Nov\u00e1k, B. & Tyson, J. J. Analysis of a generic model of eukaryotic cell-cycle regulation. Biophys. J. 90, 4361\u20134379 (2006).","journal-title":"Biophys. J."},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/nrm2530","volume":"9","author":"B Nov\u00e1k","year":"2008","unstructured":"Nov\u00e1k, B. & Tyson, J. J. Design principles of biochemical oscillators. Nat. Rev. Mol. Cell Biol. 9, 981\u2013991 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/bib\/bbp005","volume":"10","author":"A Csik\u00e1sz-Nagy","year":"2009","unstructured":"Csik\u00e1sz-Nagy, A. Computational systems biology of the cell cycle. Brief. Bioinform. 10, 424\u2013434 (2009).","journal-title":"Brief. Bioinform."},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cell.2011.03.006","volume":"144","author":"JE Ferrell","year":"2011","unstructured":"Ferrell, J. E., Tsai, T. Y.-C. & Yang, Q. Modeling the cell cycle: why do certain circuits oscillate? Cell 144, 874\u2013885 (2011).","journal-title":"Cell"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1046\/j.1432-1327.2000.01197.x","volume":"267","author":"BN Kholodenko","year":"2000","unstructured":"Kholodenko, B. N. Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur. J. Biochem. 267, 1583\u20131588 (2000).","journal-title":"Eur. J. Biochem."},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cell.2012.05.044","volume":"150","author":"JR Karr","year":"2012","unstructured":"Karr, J. R. et al. A whole-cell computational model predicts phenotype from genotype. Cell 150, 389\u2013401 (2012).","journal-title":"Cell"},{"key":"766_CR20","doi-asserted-by":"publisher","first-page":"e1003290","DOI":"10.1371\/journal.pcbi.1003290","volume":"9","author":"EJ Molinelli","year":"2013","unstructured":"Molinelli, E. J. et al. Perturbation biology: inferring signaling networks in cellular systems. PLoS Comput. Biol. 9, e1003290 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"766_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04640","volume":"4","author":"A Korkut","year":"2015","unstructured":"Korkut, A. et al. Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells. Elife 4, e04640 (2015).","journal-title":"Elife"},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cels.2020.10.002","volume":"11","author":"L Gerosa","year":"2020","unstructured":"Gerosa, L. et al. Receptor-driven ERK pulses reconfigure MAPK signaling and enable persistence of drug-adapted BRAF-mutant melanoma cells. Cell Syst. 11, 478\u2013494.e9 (2020).","journal-title":"Cell Syst."},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"766_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029716","volume":"7","author":"A Romanel","year":"2012","unstructured":"Romanel, A., Jensen, L. J., Cardelli, L. & Csik\u00e1sz-Nagy, A. Transcriptional regulation is a major controller of cell cycle transition dynamics. PLoS ONE 7, e29716 (2012).","journal-title":"PLoS ONE"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s44276-024-00097-z","volume":"2","author":"S Bhattarai","year":"2024","unstructured":"Bhattarai, S. et al. Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer. BJC Rep. 2, 87 (2024).","journal-title":"BJC Rep."},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/msb.2009.87","volume":"5","author":"J Saez-Rodriguez","year":"2009","unstructured":"Saez-Rodriguez, J. et al. Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol. Syst. Biol. 5, 331 (2009).","journal-title":"Mol. Syst. Biol."},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.biocel.2007.04.022","volume":"39","author":"C Busch","year":"2007","unstructured":"Busch, C. et al. The G2\/M checkpoint phosphatase cdc25C is located within centrosomes. Int. J. Biochem. Cell Biol. 39, 1707\u20131713 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1002\/j.1460-2075.1995.tb07210.x","volume":"14","author":"CH McGowan","year":"1995","unstructured":"McGowan, C. H. & Russell, P. Cell cycle regulation of human WEE1. EMBO J. 14, 2166\u20132175 (1995).","journal-title":"EMBO J."},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"828684","DOI":"10.3389\/fonc.2022.828684","volume":"12","author":"AB Bukhari","year":"2022","unstructured":"Bukhari, A. B., Chan, G. K. & Gamper, A. M. Targeting the DNA damage response for cancer therapy by inhibiting the kinase Wee1. Front. Oncol. 12, 828684 (2022).","journal-title":"Front. Oncol."},{"key":"766_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/sj.embor.embor887","volume":"4","author":"M Donzelli","year":"2003","unstructured":"Donzelli, M. & Draetta, G. F. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep. 4, 671\u2013677 (2003).","journal-title":"EMBO Rep."},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.277.5331.1497","volume":"277","author":"Y Sanchez","year":"1997","unstructured":"Sanchez, Y. et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497\u20131501 (1997).","journal-title":"Science"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/sj.bjc.6604208","volume":"98","author":"N Bucher","year":"2008","unstructured":"Bucher, N. & Britten, C. D. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br. J. Cancer 98, 523\u2013528 (2008).","journal-title":"Br. J. Cancer"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1074\/jbc.275.8.5600","volume":"275","author":"PR Graves","year":"2000","unstructured":"Graves, P. R. et al. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 275, 5600\u20135605 (2000).","journal-title":"J. Biol. Chem."},{"key":"766_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1747-1028-5-12","volume":"5","author":"GH Enders","year":"2010","unstructured":"Enders, G. H. Gauchos and ochos: a Wee1-Cdk tango regulating mitotic entry. Cell Div. 5, 12 (2010).","journal-title":"Cell Div."},{"key":"766_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molcel.2010.02.023","volume":"37","author":"RW Deibler","year":"2010","unstructured":"Deibler, R. W. & Kirschner, M. W. Quantitative reconstitution of mitotic CDK1 activation in somatic cell extracts. Mol. Cell 37, 753\u2013767 (2010).","journal-title":"Mol. Cell"},{"key":"766_CR36","doi-asserted-by":"publisher","first-page":"13625","DOI":"10.1093\/nar\/gkae988","volume":"52","author":"C-C Hsu","year":"2024","unstructured":"Hsu, C.-C., Yao, X., Chen, S.-Y., Tsuo, T.-C. & Wang, I.-C. The conformation of FOXM1 homodimers in vivo is crucial for regulating transcriptional activities. Nucleic Acids Res. 52, 13625\u201313643 (2024).","journal-title":"Nucleic Acids Res."},{"key":"766_CR37","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1093\/emboj\/cdg426","volume":"22","author":"J M\u00fcller","year":"2003","unstructured":"M\u00fcller, J., Ritt, D. A., Copeland, T. D. & Morrison, D. K. Functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate. EMBO J. 22, 4431\u20134442 (2003).","journal-title":"EMBO J."},{"key":"766_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11010-016-2693-2","volume":"416","author":"S Sur","year":"2016","unstructured":"Sur, S. & Agrawal, D. K. Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies. Mol. Cell Biochem. 416, 33\u201346 (2016).","journal-title":"Mol. Cell Biochem."},{"key":"766_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-020-00959-2","volume":"13","author":"A Ghelli Luserna di Ror\u00e0","year":"2020","unstructured":"Ghelli Luserna di Ror\u00e0, A., Cerchione, C., Martinelli, G. & Simonetti, G. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. J. Hematol. Oncol. 13, 126 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"766_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/emboj\/16.3.545","volume":"16","author":"MJ O\u2019Connell","year":"1997","unstructured":"O\u2019Connell, M. J., Raleigh, J. M., Verkade, H. M. & Nurse, P. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J. 16, 545\u2013554 (1997).","journal-title":"EMBO J."},{"key":"766_CR41","doi-asserted-by":"crossref","unstructured":"Dematt\u00e9, L., Priami, C. & Romanel, A. The BlenX language: a tutorial. in Formal Methods for Computational Systems Biology (eds Bernardo, M., Degano, P. & Zavattaro, G.) vol. 5016 313\u2013365 (Springer Berlin Heidelberg, 2008).","DOI":"10.1007\/978-3-540-68894-5_9"},{"key":"766_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/bib\/bbn023","volume":"9","author":"L Dematt\u00e9","year":"2008","unstructured":"Dematt\u00e9, L., Priami, C. & Romanel, A. The Beta Workbench: a computational tool to study the dynamics of biological systems. Brief. Bioinform. 9, 437\u2013449 (2008).","journal-title":"Brief. Bioinform."},{"key":"766_CR43","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/j100540a008","volume":"81","author":"DT Gillespie","year":"1977","unstructured":"Gillespie, D. T. Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem. 81, 2340\u20132361 (1977).","journal-title":"J. Phys. Chem."},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"766_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02533-6","volume":"22","author":"C Wilks","year":"2021","unstructured":"Wilks, C. et al. recount3: summaries and queries for large-scale RNA-seq expression and splicing. Genome Biol. 22, 323 (2021).","journal-title":"Genome Biol."},{"key":"766_CR46","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","DOI":"10.1038\/ng.2764"},{"key":"766_CR47","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416.e11 (2018).","journal-title":"Cell"},{"key":"766_CR48","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/jnci\/djaa201","volume":"113","author":"TO Nielsen","year":"2021","unstructured":"Nielsen, T. O. et al. Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group. J. Natl. Cancer Inst. 113, 808\u2013819 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"766_CR49","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik, S. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817\u20132826 (2004).","journal-title":"N. Engl. J. Med."},{"key":"766_CR50","doi-asserted-by":"publisher","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model. https:\/\/doi.org\/10.1007\/978-1-4757-3294-8 (Springer New York, 2000).","DOI":"10.1007\/978-1-4757-3294-8"}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00766-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00766-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00766-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:07Z","timestamp":1789556587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00766-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00766-4","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"138"}}